Location History:
- Louvain-la-neuve, BE (2012)
- Walhain, BE (2018)
Company Filing History:
Years Active: 2012-2018
Title: Michel Ghyoot: Innovator in Radioisotope Production
Introduction
Michel Ghyoot is a notable inventor based in Louvain-la-Neuve, Belgium. He has made significant contributions to the field of particle beam technology and radioisotope production. With a total of three patents to his name, Ghyoot's work has advanced the capabilities of cyclotrons and radioisotope generation.
Latest Patents
Ghyoot's latest patents include a process and installation for producing radioisotopes. This invention involves a method for producing a radioisotope by irradiating a volume of radioisotope-precursor fluid contained in a sealed cell using a particle accelerator. The method allows for the internal pressure in the sealed cell to vary freely during irradiation, with interruptions or intensity reductions based on pressure deviations.
Another significant patent is for a twin internal ion source for particle beam production with a cyclotron. This innovation features a cyclotron that includes two internal ion sources, enhancing uptime and reliability while reducing maintenance needs. The design optimizes the geometry of the cyclotron's central region and adapts the shapes of the ion sources to minimize particle losses during acceleration.
Career Highlights
Michel Ghyoot is currently employed at Ion Beam Applications S.A., a company known for its advancements in ion beam technology. His work has been instrumental in developing methods that improve the efficiency and reliability of particle accelerators.
Collaborations
Ghyoot has collaborated with notable colleagues such as Jean-Claude Amelia and Willem Kleeven. Their combined expertise has contributed to the success of various projects within the field of particle beam technology.
Conclusion
Michel Ghyoot's innovative contributions to radioisotope production and cyclotron technology highlight his role as a leading inventor in his field. His patents reflect a commitment to advancing scientific methods and improving the reliability of particle accelerators.